APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital Injectable Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hospital Injectable Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchHospital Injectable Drugs Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital Injectable Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Hospital Injectable Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital Injectable Drugs Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital Injectable Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Hospital Injectable Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hospital Injectable Drugs include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent) and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Hospital Injectable Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hospital Injectable Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hospital Injectable Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hospital Injectable Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Hospital Injectable Drugs Segment by Company

Hospira (Pfizer Inc.)

Baxter

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Otsuka

B.Braun

JW Life Science

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Sichuan Kelun Pharmaceutical

Cisen Pharmaceutical

Shijiazhuang No. 4 Pharmaceutical

Shandong Hualu Pharmaceutical

CR Double-Crane

Hospital Injectable Drugs Segment by Type

Generic Sterile Injectables

Sterile Intravenous (IV) Solutions

Hospital Injectable Drugs Segment by Application

Oncology

Anesthesia

Anti-Infectives

Parenteral Nutrition

Cardiovascular Diseases

Hospital Injectable Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Injectable Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hospital Injectable Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hospital Injectable Drugs industry.

Chapter 3: Detailed analysis of Hospital Injectable Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital Injectable Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Generic Sterile Injectables Table 3. Key Players of Sterile Intravenous (IV) Solutions Table 4. Global Hospital Injectable Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Oncology Table 6. Key Players of Anesthesia Table 7. Key Players of Anti-Infectives Table 8. Key Players of Parenteral Nutrition Table 9. Key Players of Cardiovascular Diseases Table 10. Global Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Hospital Injectable Drugs Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Hospital Injectable Drugs Market Share by Region (2021-2026) Table 13. Global Hospital Injectable Drugs Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Hospital Injectable Drugs Market Share by Region (2027-2032) Table 15. Hospital Injectable Drugs Industry Trends Table 16. Hospital Injectable Drugs Industry Drivers Table 17. Hospital Injectable Drugs Industry Opportunities and Challenges Table 18. Hospital Injectable Drugs Industry Restraints Table 19. Global Hospital Injectable Drugs Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Hospital Injectable Drugs Revenue Market Share by Company (2021-2026) Table 21. Global Hospital Injectable Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Hospital Injectable Drugs Key Company Head Office and Area Served Table 23. Global Hospital Injectable Drugs Company, Product Type & Application Table 24. Global Hospital Injectable Drugs Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Hospital Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Hospital Injectable Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Hospital Injectable Drugs Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Hospital Injectable Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Hospital Injectable Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Hospital Injectable Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Hospital Injectable Drugs Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Hospital Injectable Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Hospital Injectable Drugs Revenue Market Share by Application (2027-2032) Table 37. Hospira (Pfizer Inc.) Company Information Table 38. Hospira (Pfizer Inc.) Business Overview Table 39. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Portfolio Table 41. Hospira (Pfizer Inc.) Recent Development Table 42. Baxter Company Information Table 43. Baxter Business Overview Table 44. Baxter Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Baxter Hospital Injectable Drugs Product Portfolio Table 46. Baxter Recent Development Table 47. Fresenius Kabi Company Information Table 48. Fresenius Kabi Business Overview Table 49. Fresenius Kabi Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Fresenius Kabi Hospital Injectable Drugs Product Portfolio Table 51. Fresenius Kabi Recent Development Table 52. Sandoz (Novartis) Company Information Table 53. Sandoz (Novartis) Business Overview Table 54. Sandoz (Novartis) Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio Table 56. Sandoz (Novartis) Recent Development Table 57. Hikma Pharmaceuticals PLC Company Information Table 58. Hikma Pharmaceuticals PLC Business Overview Table 59. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Portfolio Table 61. Hikma Pharmaceuticals PLC Recent Development Table 62. Dr. Reddy’s Laboratories Ltd Company Information Table 63. Dr. Reddy’s Laboratories Ltd Business Overview Table 64. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Portfolio Table 66. Dr. Reddy’s Laboratories Ltd Recent Development Table 67. Grifols Company Information Table 68. Grifols Business Overview Table 69. Grifols Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Grifols Hospital Injectable Drugs Product Portfolio Table 71. Grifols Recent Development Table 72. Nichi-Iko Group (Sagent) Company Information Table 73. Nichi-Iko Group (Sagent) Business Overview Table 74. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio Table 76. Nichi-Iko Group (Sagent) Recent Development Table 77. Teva Pharmaceutical Company Information Table 78. Teva Pharmaceutical Business Overview Table 79. Teva Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 81. Teva Pharmaceutical Recent Development Table 82. Otsuka Company Information Table 83. Otsuka Business Overview Table 84. Otsuka Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Otsuka Hospital Injectable Drugs Product Portfolio Table 86. Otsuka Recent Development Table 87. B.Braun Company Information Table 88. B.Braun Business Overview Table 89. B.Braun Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. B.Braun Hospital Injectable Drugs Product Portfolio Table 91. B.Braun Recent Development Table 92. JW Life Science Company Information Table 93. JW Life Science Business Overview Table 94. JW Life Science Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. JW Life Science Hospital Injectable Drugs Product Portfolio Table 96. JW Life Science Recent Development Table 97. Auromedics Company Information Table 98. Auromedics Business Overview Table 99. Auromedics Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Auromedics Hospital Injectable Drugs Product Portfolio Table 101. Auromedics Recent Development Table 102. Sanofi Company Information Table 103. Sanofi Business Overview Table 104. Sanofi Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Sanofi Hospital Injectable Drugs Product Portfolio Table 106. Sanofi Recent Development Table 107. Gland Pharma Company Information Table 108. Gland Pharma Business Overview Table 109. Gland Pharma Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Gland Pharma Hospital Injectable Drugs Product Portfolio Table 111. Gland Pharma Recent Development Table 112. Endo International PLC Company Information Table 113. Endo International PLC Business Overview Table 114. Endo International PLC Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Endo International PLC Hospital Injectable Drugs Product Portfolio Table 116. Endo International PLC Recent Development Table 117. Sichuan Kelun Pharmaceutical Company Information Table 118. Sichuan Kelun Pharmaceutical Business Overview Table 119. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 121. Sichuan Kelun Pharmaceutical Recent Development Table 122. Cisen Pharmaceutical Company Information Table 123. Cisen Pharmaceutical Business Overview Table 124. Cisen Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Cisen Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 126. Cisen Pharmaceutical Recent Development Table 127. Shijiazhuang No. 4 Pharmaceutical Company Information Table 128. Shijiazhuang No. 4 Pharmaceutical Business Overview Table 129. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 131. Shijiazhuang No. 4 Pharmaceutical Recent Development Table 132. Shandong Hualu Pharmaceutical Company Information Table 133. Shandong Hualu Pharmaceutical Business Overview Table 134. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 136. Shandong Hualu Pharmaceutical Recent Development Table 137. CR Double-Crane Company Information Table 138. CR Double-Crane Business Overview Table 139. CR Double-Crane Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. CR Double-Crane Hospital Injectable Drugs Product Portfolio Table 141. CR Double-Crane Recent Development Table 142. North America Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 143. North America Hospital Injectable Drugs Market Size by Type (2027-2032) & (US$ Million) Table 144. North America Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 145. North America Hospital Injectable Drugs Market Size by Application (2027-2032) & (US$ Million) Table 146. North America Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Hospital Injectable Drugs Market Size by Country (2021-2026) Table 148. North America Hospital Injectable Drugs Market Size by Country (2027-2032) Table 149. Europe Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 150. Europe Hospital Injectable Drugs Market Size by Type (2027-2032) & (US$ Million) Table 151. Europe Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 152. Europe Hospital Injectable Drugs Market Size by Application (2027-2032) & (US$ Million) Table 153. Europe Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Hospital Injectable Drugs Market Size by Country (2021-2026) Table 155. Europe Hospital Injectable Drugs Market Size by Country (2027-2032) Table 156. China Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 157. China Hospital Injectable Drugs Market Size by Type (2027-2032) & (US$ Million) Table 158. China Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 159. China Hospital Injectable Drugs Market Size by Application (2027-2032) & (US$ Million) Table 160. Asia Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 161. Asia Hospital Injectable Drugs Market Size by Type (2027-2032) & (US$ Million) Table 162. Asia Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 163. Asia Hospital Injectable Drugs Market Size by Application (2027-2032) & (US$ Million) Table 164. Asia Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Hospital Injectable Drugs Market Size by Country (2021-2026) Table 166. Asia Hospital Injectable Drugs Market Size by Country (2027-2032) Table 167. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 168. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Type (2027-2032) & (US$ Million) Table 169. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 170. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Application (2027-2032) & (US$ Million) Table 171. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country (2021-2026) Table 173. South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country (2027-2032) Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Hospital Injectable Drugs Product Image Figure 2. Global Hospital Injectable Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Hospital Injectable Drugs Market Share by Type: 2025 VS 2032 Figure 4. Generic Sterile Injectables Image Figure 5. Sterile Intravenous (IV) Solutions Image Figure 6. Global Hospital Injectable Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Hospital Injectable Drugs Market Share by Application: 2025 VS 2032 Figure 8. Oncology Image Figure 9. Anesthesia Image Figure 10. Anti-Infectives Image Figure 11. Parenteral Nutrition Image Figure 12. Cardiovascular Diseases Image Figure 13. Global Hospital Injectable Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Hospital Injectable Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Hospital Injectable Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Hospital Injectable Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Hospital Injectable Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Hospital Injectable Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Hospital Injectable Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hospital Injectable Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Hospital Injectable Drugs Market Share by Type (2021-2032) Figure 26. North America Hospital Injectable Drugs Market Share by Application (2021-2032) Figure 27. North America Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 28. United States Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Hospital Injectable Drugs Market Share by Type (2021-2032) Figure 33. Europe Hospital Injectable Drugs Market Share by Application (2021-2032) Figure 34. Europe Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 35. Germany Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Hospital Injectable Drugs Market Share by Type (2021-2032) Figure 43. China Hospital Injectable Drugs Market Share by Application (2021-2032) Figure 44. Asia Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Hospital Injectable Drugs Market Share by Type (2021-2032) Figure 46. Asia Hospital Injectable Drugs Market Share by Application (2021-2032) Figure 47. Asia Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 48. Japan Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Hospital Injectable Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Hospital Injectable Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 58. Brazil Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Sterile Injectables
  • Sterile Intravenous (IV) Solutions
Applications
  • Oncology
  • Anesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • Cardiovascular Diseases
Companies covered
  • Hospira (Pfizer Inc.)
  • Baxter
  • Fresenius Kabi
  • Sandoz (Novartis)
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy’s Laboratories Ltd
  • Grifols
  • Nichi-Iko Group (Sagent)
  • Teva Pharmaceutical
  • Otsuka
  • B.Braun
  • JW Life Science
  • Auromedics
  • Sanofi
  • Gland Pharma
  • Endo International PLC
  • Sichuan Kelun Pharmaceutical
  • Cisen Pharmaceutical
  • Shijiazhuang No. 4 Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • CR Double-Crane

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Generic Sterile Injectables
  5. 1.2.3 Sterile Intravenous (IV) Solutions
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Oncology
  9. 1.3.3 Anesthesia
  10. 1.3.4 Anti-Infectives
  11. 1.3.5 Parenteral Nutrition
  12. 1.3.6 Cardiovascular Diseases
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Hospital Injectable Drugs Growth Trends by Region
  15. 1.5.1 Global Hospital Injectable Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Hospital Injectable Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Hospital Injectable Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Hospital Injectable Drugs Market Dynamics
  1. 2.1 Hospital Injectable Drugs Industry Trends
  2. 2.2 Hospital Injectable Drugs Industry Drivers
  3. 2.3 Hospital Injectable Drugs Industry Opportunities and Challenges
  4. 2.4 Hospital Injectable Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Hospital Injectable Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Hospital Injectable Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Hospital Injectable Drugs Key Company Head office and Area Served
  4. 3.4 Global Hospital Injectable Drugs Company, Product Type & Application
  5. 3.5 Global Hospital Injectable Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Hospital Injectable Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Hospital Injectable Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Hospital Injectable Drugs Tier 1, Tier 2, and Tier 3
4 Hospital Injectable Drugs Market by Type
  1. 4.1 Global Hospital Injectable Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Hospital Injectable Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Hospital Injectable Drugs Market Size Share by Type (2021-2032)
5 Hospital Injectable Drugs Market by Application
  1. 5.1 Global Hospital Injectable Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Hospital Injectable Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Hospital Injectable Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hospira (Pfizer Inc.)
  2. 6.1.1 Hospira (Pfizer Inc.) Company Information
  3. 6.1.2 Hospira (Pfizer Inc.) Business Overview
  4. 6.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Portfolio
  6. 6.1.5 Hospira (Pfizer Inc.) Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Baxter Hospital Injectable Drugs Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Fresenius Kabi Hospital Injectable Drugs Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Sandoz (Novartis)
  20. 6.4.1 Sandoz (Novartis) Company Information
  21. 6.4.2 Sandoz (Novartis) Business Overview
  22. 6.4.3 Sandoz (Novartis) Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio
  24. 6.4.5 Sandoz (Novartis) Recent Developments
  25. 6.5 Hikma Pharmaceuticals PLC
  26. 6.5.1 Hikma Pharmaceuticals PLC Company Information
  27. 6.5.2 Hikma Pharmaceuticals PLC Business Overview
  28. 6.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Portfolio
  30. 6.5.5 Hikma Pharmaceuticals PLC Recent Developments
  31. 6.6 Dr. Reddy’s Laboratories Ltd
  32. 6.6.1 Dr. Reddy’s Laboratories Ltd Company Information
  33. 6.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
  34. 6.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Portfolio
  36. 6.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments
  37. 6.7 Grifols
  38. 6.7.1 Grifols Company Information
  39. 6.7.2 Grifols Business Overview
  40. 6.7.3 Grifols Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Grifols Hospital Injectable Drugs Product Portfolio
  42. 6.7.5 Grifols Recent Developments
  43. 6.8 Nichi-Iko Group (Sagent)
  44. 6.8.1 Nichi-Iko Group (Sagent) Company Information
  45. 6.8.2 Nichi-Iko Group (Sagent) Business Overview
  46. 6.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio
  48. 6.8.5 Nichi-Iko Group (Sagent) Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Otsuka
  56. 6.10.1 Otsuka Company Information
  57. 6.10.2 Otsuka Business Overview
  58. 6.10.3 Otsuka Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Otsuka Hospital Injectable Drugs Product Portfolio
  60. 6.10.5 Otsuka Recent Developments
  61. 6.11 B.Braun
  62. 6.11.1 B.Braun Company Information
  63. 6.11.2 B.Braun Business Overview
  64. 6.11.3 B.Braun Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 B.Braun Hospital Injectable Drugs Product Portfolio
  66. 6.11.5 B.Braun Recent Developments
  67. 6.12 JW Life Science
  68. 6.12.1 JW Life Science Company Information
  69. 6.12.2 JW Life Science Business Overview
  70. 6.12.3 JW Life Science Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 JW Life Science Hospital Injectable Drugs Product Portfolio
  72. 6.12.5 JW Life Science Recent Developments
  73. 6.13 Auromedics
  74. 6.13.1 Auromedics Company Information
  75. 6.13.2 Auromedics Business Overview
  76. 6.13.3 Auromedics Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Auromedics Hospital Injectable Drugs Product Portfolio
  78. 6.13.5 Auromedics Recent Developments
  79. 6.14 Sanofi
  80. 6.14.1 Sanofi Company Information
  81. 6.14.2 Sanofi Business Overview
  82. 6.14.3 Sanofi Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Sanofi Hospital Injectable Drugs Product Portfolio
  84. 6.14.5 Sanofi Recent Developments
  85. 6.15 Gland Pharma
  86. 6.15.1 Gland Pharma Company Information
  87. 6.15.2 Gland Pharma Business Overview
  88. 6.15.3 Gland Pharma Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Gland Pharma Hospital Injectable Drugs Product Portfolio
  90. 6.15.5 Gland Pharma Recent Developments
  91. 6.16 Endo International PLC
  92. 6.16.1 Endo International PLC Company Information
  93. 6.16.2 Endo International PLC Business Overview
  94. 6.16.3 Endo International PLC Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Endo International PLC Hospital Injectable Drugs Product Portfolio
  96. 6.16.5 Endo International PLC Recent Developments
  97. 6.17 Sichuan Kelun Pharmaceutical
  98. 6.17.1 Sichuan Kelun Pharmaceutical Company Information
  99. 6.17.2 Sichuan Kelun Pharmaceutical Business Overview
  100. 6.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio
  102. 6.17.5 Sichuan Kelun Pharmaceutical Recent Developments
  103. 6.18 Cisen Pharmaceutical
  104. 6.18.1 Cisen Pharmaceutical Company Information
  105. 6.18.2 Cisen Pharmaceutical Business Overview
  106. 6.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Product Portfolio
  108. 6.18.5 Cisen Pharmaceutical Recent Developments
  109. 6.19 Shijiazhuang No. 4 Pharmaceutical
  110. 6.19.1 Shijiazhuang No. 4 Pharmaceutical Company Information
  111. 6.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
  112. 6.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio
  114. 6.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments
  115. 6.20 Shandong Hualu Pharmaceutical
  116. 6.20.1 Shandong Hualu Pharmaceutical Company Information
  117. 6.20.2 Shandong Hualu Pharmaceutical Business Overview
  118. 6.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio
  120. 6.20.5 Shandong Hualu Pharmaceutical Recent Developments
  121. 6.21 CR Double-Crane
  122. 6.21.1 CR Double-Crane Company Information
  123. 6.21.2 CR Double-Crane Business Overview
  124. 6.21.3 CR Double-Crane Hospital Injectable Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 CR Double-Crane Hospital Injectable Drugs Product Portfolio
  126. 6.21.5 CR Double-Crane Recent Developments
7 North America
  1. 7.1 North America Hospital Injectable Drugs Market Size (2021-2032)
  2. 7.2 North America Hospital Injectable Drugs Market Size by Type
  3. 7.2.1 North America Hospital Injectable Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Hospital Injectable Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Hospital Injectable Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Hospital Injectable Drugs Market Size by Application
  7. 7.3.1 North America Hospital Injectable Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Hospital Injectable Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Hospital Injectable Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Hospital Injectable Drugs Market Size by Country
  11. 7.4.1 North America Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Hospital Injectable Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Hospital Injectable Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Hospital Injectable Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Hospital Injectable Drugs Market Size (2021-2032)
  2. 8.2 Europe Hospital Injectable Drugs Market Size by Type
  3. 8.2.1 Europe Hospital Injectable Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Hospital Injectable Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Hospital Injectable Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Hospital Injectable Drugs Market Size by Application
  7. 8.3.1 Europe Hospital Injectable Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Hospital Injectable Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Hospital Injectable Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Hospital Injectable Drugs Market Size by Country
  11. 8.4.1 Europe Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Hospital Injectable Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Hospital Injectable Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Hospital Injectable Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Hospital Injectable Drugs Market Size (2021-2032)
  2. 9.2 China Hospital Injectable Drugs Market Size by Type
  3. 9.2.1 China Hospital Injectable Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Hospital Injectable Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Hospital Injectable Drugs Market Share by Type (2021-2032)
  6. 9.3 China Hospital Injectable Drugs Market Size by Application
  7. 9.3.1 China Hospital Injectable Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Hospital Injectable Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Hospital Injectable Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Hospital Injectable Drugs Market Size (2021-2032)
  2. 10.2 Asia Hospital Injectable Drugs Market Size by Type
  3. 10.2.1 Asia Hospital Injectable Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Hospital Injectable Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Hospital Injectable Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Hospital Injectable Drugs Market Size by Application
  7. 10.3.1 Asia Hospital Injectable Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Hospital Injectable Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Hospital Injectable Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Hospital Injectable Drugs Market Size by Country
  11. 10.4.1 Asia Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Hospital Injectable Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Hospital Injectable Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Hospital Injectable Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Hospital Injectable Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Hospital Injectable Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Hospital Injectable Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Hospital Injectable Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Hospital Injectable Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst